Cancer risk in <it>MLH1</it>, <it>MSH2 </it>and <it>MSH6 </it>mutation carriers; different risk profiles may influence clinical management
Ramsoekh Dewkoemar, Wagner Anja, van Leerdam Monique E and 4 more
Hereditary Cancer in Clinical Practice · 2009
doi:10.1186/1897-4287-7-17 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Background</p> <p>Lynch syndrome (LS) is associated with a high risk for colorectal cancer (CRC) and extracolonic malignancies, such as endometrial carcinoma (EC). The risk is dependent of the affected mismatch repair gene. The aim of the present study was to calculate the cumulative risk of LS related cancers in proven <it>MLH1</it>, <it>MSH2 </it>and <it>MSH6 </it>mutation carriers.</p> <p>Methods</p> <p>The studypopulation consisted out of 67 proven LS families. Clinical information including mutation status and tumour diagnosis was collected. Cumulative risks were calculated and compared using Kaplan Meier survival analysis.</p> <p>Results</p> <p><it>MSH6 </it>mutation carriers, both males and females had the lowest risk for developing CRC at age 70 years, 54% and 30% respectively and the age of onset was delayed by 3-5 years in males. With respect to endometrial carcinoma, female <it>MSH6 </it>mutation carriers had the highest risk at age 70 years (61%) compared to <it>MLH1 </it>(25%) and <it>MSH2 </it>(49%). Also, the age of EC onset was delayed by 5-10 years in comparison with <it>MLH1 </it>and <it>MSH2</it>.</p> <p>Conclusions</p> <p>Although the cumulative lifetime risk of LS related cancer is similar, <it>MLH1</it>, <it>MSH2 </it>and <it>MSH6 </it>mutations seem to cause distinguishable cancer risk profiles. Female <it>MSH6 </it>mutation carriers have a lower CRC risk and a higher risk for developing endometrial carcinoma. As a consequence, surveillance colonoscopy starting at age 30 years instead of 20-25 years is more suitable. Also, prophylactic hysterectomy may be more indicated in female <it>MSH6 </it>mutation carriers compared to <it>MLH1 </it>and <it>MSH2 </it>mutation carriers.</p>
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.